NASDAQ:APGE | Profit Breakdown | Apogee Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$96M-$85.78M-$85.85M
2026-03-31-$82.77M-$74.03M-$74.11M
2025-12-31-$78.06M-$69.33M-$69.39M
2025-09-30-$71.28M-$64.96M-$65.02M
2025-06-30-$73.17M-$66.02M-$66.1M
2025-03-31-$63.1M-$55.26M-$55.34M
2024-12-31-$75.88M-$67.2M-$67.22M
2024-09-30-$58.69M-$49.02M-$49.02M
2024-06-30-$44.12M-$33.82M-$33.82M
2024-03-31-$38.18M-$32.09M-$32.09M
2023-12-31-$37.16M-$31.74M
2023-09-30-$24.31M-$20.84M
2023-06-30-$18.89M-$18.89M
2023-03-31-$12.66M-$12.53M
2022-12-31-$14.1M-$14.01M
2022-09-30-$10.51M-$19.66M
2022-06-30-$1.82M-$1.82M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$285.6M-$255.57M-$255.84M
2024-12-31-$216.87M-$182.13M-$182.15M
2023-12-31-$93M-$83.99M-$83.99M
2022-12-31-$30.73M-$39.79M